Cardiovascular investors
7 investors that name Cardiovascular among their sectors are recorded here: 4 venture capital firms, 1 corporate venture arm, 1 investor and 1 venture studio. Stated investment stages run from pre-seed to growth. Most are headquartered in Australia (1), Italy (1) and the Netherlands (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Brandon Capital Partners life science · medical devices · oncology · neuroscience |
Direct investor | Venture capital | Seed – Growth | Melbourne, Australia |
| Hadean Ventures life sciences · healthcare · oncology · cardiovascular |
Direct investor | Venture capital | Not stated | Oslo, Norway |
| Johnson & Johnson Innovation – JJDC pharmaceuticals · medtech · oncology · immunology |
Direct investor | Corporate venture | Seed – Growth | |
| JSTAR Capital Investments Med-Tech · Cardiovascular · Orthopedic · BioPharma |
Direct investor | Venture capital | Series B | |
| NLC Health Ventures healthcare · medtech · biotech · digital health |
Direct investor | Venture studio | Pre-seed – Series B | Amsterdam, Netherlands |
| Panakes Partners Life Sciences · Biotech · Medical Devices · Therapeutics |
Direct investor | Venture capital | Seed – Series A | Milan, Italy |
| TechWald Holding S.p.A. MedTech · medical devices · healthcare · cardiovascular |
Direct investor | Other | Seed – Series A |